PARAMETRIC PORTFOLIO ASSOCIATES LLC - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 137 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 8.14 and the average weighting 0.3%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$796,000
+9.0%
42,209
-31.9%
0.00%0.0%
Q2 2019$730,000
-13.1%
62,015
+0.7%
0.00%0.0%
Q1 2019$840,000
+37.3%
61,559
+3.1%
0.00%0.0%
Q4 2018$612,000
-41.0%
59,717
-4.2%
0.00%0.0%
Q3 2018$1,038,000
+1.4%
62,339
-3.8%
0.00%0.0%
Q2 2018$1,024,000
+32.1%
64,815
+6.2%
0.00%0.0%
Q1 2018$775,000
-3.0%
61,022
-12.6%
0.00%0.0%
Q4 2017$799,000
+90.7%
69,804
+104.1%
0.00%
Q3 2017$419,000
-18.8%
34,194
-24.1%
0.00%
-100.0%
Q2 2017$516,000
+26.5%
45,060
+129.5%
0.00%0.0%
Q1 2017$408,000
-28.4%
19,635
-28.3%
0.00%0.0%
Q4 2016$570,000
-73.8%
27,382
-58.7%
0.00%
-66.7%
Q3 2016$2,175,000
+29.0%
66,369
-1.7%
0.00%0.0%
Q2 2016$1,686,000
+68.9%
67,504
+65.7%
0.00%
+50.0%
Q1 2016$998,000
+121.3%
40,737
+198.1%
0.00%
+100.0%
Q4 2015$451,00013,6650.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Novo Holdings A/S 6,402,366$128,496,0006.43%
Cormorant Asset Management, LP 150,000$3,011,0000.80%
PFM Health Sciences, LP 738,027$14,812,0000.30%
Partner Investment Management, L.P. 27,893$560,0000.11%
Spark Investment Management LLC 32,100$642,0000.10%
PointState Capital LP 275,000$5,519,0000.07%
DRIEHAUS CAPITAL MANAGEMENT LLC 97,809$1,963,0000.06%
CADIAN CAPITAL MANAGEMENT, LP 100,000$2,007,0000.06%
Nicholas Investment Partners, LP 50,456$1,013,0000.06%
Baker Brothers Advisors 153,350$3,078,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders